Impact of Ascorbic Acid on Post-Cardiothoracic Surgery Inflammation
Completed · Phase 4 · Has a placebo group
Conditions studied: Cardiac Surgery, Inflammation
In brief
The purpose of this study is to see if ascorbic acid (Vitamin-C) therapy will reduce inflammation following heart surgery.
Key facts
- Study ID
- NCT00519337
- Run by
- Hartford Hospital
- People needed
- 25
- Starts
- 2008-10-01
- Expected to finish
- 2011-04-01
- Last updated by the study team
- 2012-01-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Cardiothoracic surgery
You may not qualify if…
- Pregnancy
- Prior hypersensitivity to ascorbic acid
- Renal Calculi
Where it is running
- Hartford Hosptial — Hartford, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.